Research & Literature

Myasthenia Gravis in Pregnancy.

Roth CK, Dent S, McDevitt K

Nursing for women's health 2015; (19(3)):248-52 doi:10.1111/1751-486X.12206.

Repetitive nerve stimulation and single-fiber electromyography in the evaluation of patients with suspected myasthenia gravis or Lambert-Eaton myasthenic syndrome: Review of recent literature.

Chiou-Tan FY, Gilchrist JM

Muscle & nerve 2015; (52(3)):455-62 doi:10.1002/mus.24745.

Efficacy of prednisone for the treatment of ocular myasthenia (EPITOME): A randomized, controlled trial.

Benatar M, Mcdermott MP, Sanders DB, et al.

Muscle & nerve 2016; (53(3)):363-9 doi:10.1002/mus.24769.

[VATS THYMECTOMY IN MYASTHENIA GRAVIS TREATMENT--A CASE REPORT].

Krnić D, Juričić J, Ilić N, Jerčić A

Lijecnicki vjesnik 2015; (137(5-6)):177-80.

Presynaptic Disorders: Lambert-Eaton Myasthenic Syndrome and Botulism.

Gable KL, Massey JM

Seminars in neurology 2015; (35(4)):340-6 doi:10.1055/s-0035-1558976.

Clinical outcome of generalized myasthenia gravis in Hong Kong Chinese.

Lee CY, Lam CL, Pang SY, et al.

Journal of neuroimmunology 2015; (289()):177-81.

[Myasthenia gravis].

Schodrowski J, Seipelt M, Adibi-Sedeh I, et al.

Der Internist 2016; (57(4)):349-61 doi:10.1007/s00108-016-0035-9.

Animal models of myasthenia gravis: utility and limitations.

Mantegazza R, Cordiglieri C, Consonni A, Baggi F

International journal of general medicine 2016; (9()):53-64 doi:10.2147/IJGM.S88552.

Neuromuscular junction disorders.

Verschuuren J, Strijbos E, Vincent A

Handbook of clinical neurology 2016; (133()):447-66.

Muscle-Specific Receptor Tyrosine Kinase (MuSK) Myasthenia Gravis.

Hurst RL, Gooch CL

Current neurology and neuroscience reports 2016; (16(7)):61 doi:10.1007/s11910-016-0668-z.

Pathogenesis of myasthenia gravis: update on disease types, models, and mechanisms.

Phillips WD, Vincent A

F1000Research 2016; (5()).

[The Significance of Extended Thymectomy in Non-Thymomatous Myasthenia Gravis: an MGTX Study].

Yoshikawa H

Brain and nerve = Shinkei kenkyu no shinpo 2017; (69(1)):51-59 doi:10.11477/mf.1416200636.

Is MuSK myasthenia gravis linked to IgG4-related disease?

Raibagkar P, Ferry JA, Stone JH

Journal of neuroimmunology 2017; (305()):82-83 doi:10.1016/j.jneuroim.2017.02.004.

Ophthalmoplegia associated with lung adenocarcinoma in a patient with the Lambert-Eaton myasthenic syndrome: A case report.

Tang Y, Wang K, Chen Z, et al.

Medicine 2017; (96(22)):e6484 doi:10.1097/MD.0000000000006484.

Thymectomy is a beneficial therapy for patients with non-thymomatous ocular myasthenia gravis: a systematic review and meta-analysis.

Zhu K, Li J, Huang X, et al.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2017; (38(10)):1753-1760 doi:10.1007/s10072-017-3058-7.

Physician- and self-assessed myasthenia gravis activities of daily living score.

Lee HL, Min JH, Seok JM, et al.

Muscle & nerve 2018; (57(3)):419-422 doi:10.1002/mus.25764.

Neuromuscular synapse electrophysiology in myasthenia gravis animal models.

Plomp JJ, Huijbers MGM, Verschuuren JJGM

Annals of the New York Academy of Sciences 2018; (1412(1)):146-153 doi:10.1111/nyas.13507.

Distinguishing Features of the Repetitive Nerve Stimulation Test Between Lambert-Eaton Myasthenic Syndrome and Myasthenia Gravis, 50-Year Reappraisal.

Oh SJ

Journal of clinical neuromuscular disease 2017; (19(2)):66-75 doi:10.1097/CND.0000000000000190.

The Myasthenia Gravis-specific Activities of Daily Living scale as a useful outcome measure and in routine clinical management in Polish patients.

Rozmilowska IM, Adamczyk-Sowa MH, Czyzewski D

Neurologia i neurochirurgia polska 2018; (52(3)):368-373 doi:10.1016/j.pjnns.2017.12.012.

Efficacy of Gaze Photographs in Diagnosing Ocular Myasthenia Gravis.

Ahn J, Park KS, Kim JS, Hwang JM

Journal of clinical neurology (Seoul, Korea) 2018; (14(3)):333-338 doi:10.3988/jcn.2018.14.3.333.

Perianesthetic Implications and Considerations for Myasthenia Gravis.

Muckler VC, O'Brien JM, Matson SE, Rice AN

Journal of perianesthesia nursing : official journal of the American Society of PeriAnesthesia Nurses 2019; (34(1)):4-15 doi:10.1016/j.jopan.2018.03.009.

Treatment of Ocular Myasthenia Gravis.

Cornblath WT

Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) 2018; (7(4)):257-259 doi:10.22608/APO.2018301.

A diagnosis of late-onset Myasthenia gravis unmasked by topical antibiotics.

Hussain N, Hussain F, Haque D, Chittivelu S

Journal of community hospital internal medicine perspectives 2018; (8(4)):230-232 doi:10.1080/20009666.2018.1487245.

Clinical differences of early and late-onset myasthenia gravis in 985 patients.

Fan L, Ma S, Yang Y, et al.

Neurological research 2019; (41(1)):45-51 doi:10.1080/01616412.2018.1525121.

Recent advances in understanding and managing myasthenia gravis.

Jordan A, Freimer M

F1000Research 2018; (7()) doi:10.12688/f1000research.15973.1.

Thymectomy may not be associated with clinical improvement in MuSK myasthenia gravis.

Clifford KM, Hobson-Webb LD, Benatar M, et al.

Muscle & nerve 2019; (59(4)):404-410 doi:10.1002/mus.26404.

Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial.

Wolfe GI, Kaminski HJ, Aban IB, et al.

The Lancet. Neurology 2019; (18(3)):259-268 doi:10.1016/S1474-4422(18)30392-2.

Delayed Diagnosis of Atypical Presentation of Myasthenia Gravis.

Mustafa MS, Marshal M, Ahern E, Crowley P

European journal of case reports in internal medicine 2018; (5(2)):000785 doi:10.12890/2017_000785.

Incidence, Epidemiology, and Transformation of Ocular Myasthenia Gravis: A Population-Based Study.

Hendricks TM, Bhatti MT, Hodge DO, Chen JJ

American journal of ophthalmology 2019; (205()):99-105 doi:10.1016/j.ajo.2019.04.017.

[Eculizumab Treatment for Refractory Generalized Myasthenia Gravis].

Uzawa A, Kuwabara S

Brain and nerve = Shinkei kenkyu no shinpo 2019; (71(6)):565-570 doi:10.11477/mf.1416201317.

Single fiber electromyography.

Juel VC

Handbook of clinical neurology 2019; (160()):303-310 doi:10.1016/B978-0-444-64032-1.00019-9.

Pediatric Ocular Myasthenia Gravis.

Fisher K, Shah V

Current treatment options in neurology 2019; (21(10)):46 doi:10.1007/s11940-019-0593-y.

Myasthenia gravis: State of the art and new therapeutic strategies.

Souto EB, Lima B, Campos JR, et al.

Journal of neuroimmunology 2019; (337()):577080 doi:10.1016/j.jneuroim.2019.577080.

Update on Ocular Myasthenia Gravis.

O'Hare M, Doughty C

Seminars in neurology 2019; (39(6)):749-760 doi:10.1055/s-0039-1700527.

Clinical and therapeutic features of myasthenia gravis in adults based on age at onset.

Cortés-Vicente E, Álvarez-Velasco R, Segovia S, et al.

Neurology 2020; (94(11)):e1171-e1180 doi:10.1212/WNL.0000000000008903.

Use of rituximab in muscle-specific tyrosine kinase antibody-positive myasthenia gravis: Preliminary observations from a tertiary care center in Northern India.

Sachdeva J, Mahesh KV, Shree R, et al.

Indian journal of pharmacology 2020; (52(1)):49-52 doi:10.4103/ijp.IJP_333_18.

Celebrating the 70 years of pyridostigmine on therapy of Myasthenia Gravis: historical aspects of the preliminary trials.

Lorenzoni PJ, Kay CSK, Ducci RD, et al.

Arquivos de neuro-psiquiatria 2020; (78(3)):179-181 doi:10.1590/0004-282x20190189.

Pseudopartial Third Nerve Palsy as the Presenting Sign of Ocular Myasthenia Gravis.

Bertolet AN, Druckenbrod RC

Optometry and vision science : official publication of the American Academy of Optometry 2020; (97(5)):377-382 doi:10.1097/OPX.0000000000001512.

Adult Ocular Myasthenia Gravis Conversion: A Single-Center Retrospective Analysis in China.

Feng X, Huan X, Yan C, et al.

European neurology 2020; (83(2)):182-188 doi:10.1159/000507853.

Minimal manifestation status and prednisone withdrawal in the MGTX trial.

Lee I, Kuo HC, Aban IB, et al.

Neurology 2020; (95(6)):e755-e766 doi:10.1212/WNL.0000000000010031.

Takotsubo cardiomyopathy in the setting of a myasthenic crisis.

Ranellone A, Abraham MG

The International journal of neuroscience 2022; (132(1)):89-94 doi:10.1080/00207454.2020.1797720.

MuSK-Associated Myasthenia Gravis: Clinical Features and Management.

Rodolico C, Bonanno C, Toscano A, Vita G

Frontiers in neurology 2020; (11()):660 doi:10.3389/fneur.2020.00660.

A Review of Psychiatric Comorbidity in Myasthenia Gravis.

Law C, Flaherty CV, Bandyopadhyay S

Cureus 2020; (12(7)):e9184 doi:10.7759/cureus.9184.

Progress in the therapy of myasthenia gravis: getting closer to effective targeted immunotherapies.

Dalakas MC

Current opinion in neurology 2020; (33(5)):545-552 doi:10.1097/WCO.0000000000000858.

Myasthenia Gravis With Antibodies Against Muscle Specific Kinase: An Update on Clinical Features, Pathophysiology and Treatment.

Cao M, Koneczny I, Vincent A

Frontiers in molecular neuroscience 2020; (13()):159 doi:10.3389/fnmol.2020.00159.

Myasthenia Gravis and its Association With Thyroid Diseases.

Amin S, Aung M, Gandhi FR, et al.

Cureus 2020; (12(9)):e10248 doi:10.7759/cureus.10248.

Update in the Management of Myasthenia Gravis and Lambert-Eaton Myasthenic Syndrome.

Bodkin C, Pascuzzi RM

Neurologic clinics 2021; (39(1)):133-146 doi:10.1016/j.ncl.2020.09.007.

Ocular myasthenia gravis - How effective is low dose prednisone long term?

Verma R, Wolfe GI, Kupersmith MJ

Journal of the neurological sciences 2021; (420()):117274 doi:10.1016/j.jns.2020.117274.

Myasthenic Crisis as the First Presentation of Myasthenia Gravis: A Case Report.

Payus AO, Leow Wen Hsiang J, Leong JQ, et al.

The American journal of case reports 2021; (22()):e928419 doi:10.12659/AJCR.928419.

Risk for generalization in ocular onset myasthenia gravis: experience from a neuro-ophthalmology clinic.

Kısabay A, Özdemir HN, Gökçay F, Çelebisoy N

Acta neurologica Belgica 2022; (122(2)):337-344 doi:10.1007/s13760-020-01582-1.

Giant cell myositis associated with concurrent myasthenia gravis: a case-based review of the literature.

Scangarello FA, Angel-Buitrago L, Lang-Orsini M, et al.

Clinical rheumatology 2021; (40(9)):3841-3851 doi:10.1007/s10067-021-05619-5.

Diagnosis of Myasthenia Gravis.

Rousseff RT

Journal of clinical medicine 2021; (10(8)) doi:10.3390/jcm10081736.

Myasthenia Gravis: Epidemiology, Pathophysiology and Clinical Manifestations.

Dresser L, Wlodarski R, Rezania K, Soliven B

Journal of clinical medicine 2021; (10(11)) doi:10.3390/jcm10112235.

Cholinergic hyperactivity in patients with myasthenia gravis with MuSK antibodies: A neurophysiological study.

Modoni A, Mastrorosa A, Spagni G, Evoli A

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology 2021; (132(8)):1845-1849 doi:10.1016/j.clinph.2021.04.019.

A Case of MuSK Myasthenia Gravis Presenting With Persistent Respiratory Insufficiency.

Tsai C, Howard JF, Mehrabyan A

Journal of clinical neuromuscular disease 2021; (23(1)):39-42 doi:10.1097/CND.0000000000000374.

MuSK Myasthenia Gravis Presenting with Bilateral Vocal Cord Abduction Paresis: A Case Report and Literature Review.

Santilli A, Stitt D

The neurologist 2021; (26(5)):175-177 doi:10.1097/NRL.0000000000000339.

A Diagnostic Dilemma of Dysphonia: A Case Report on Laryngeal Myasthenia Gravis.

Khan AA, Khan MW, Kundi TA, et al.

Cureus 2021; (13(8)):e16878 doi:10.7759/cureus.16878.

Characteristics of myasthenia gravis in elderly patients: a retrospective study.

Li Y, Dong X, Li Z, et al.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2022; (43(4)):2775-2783 doi:10.1007/s10072-021-05599-z.

Adverse Side Effects Associated with Corticosteroid Therapy: A Study in 39 Patients with Generalized Myasthenia Gravis.

Johnson S, Katyal N, Narula N, Govindarajan R

Medical science monitor : international medical journal of experimental and clinical research 2021; (27()):e933296 doi:10.12659/MSM.933296.

A Targeted Complement Inhibitor CRIg/FH Protects Against Experimental Autoimmune Myasthenia Gravis in Rats via Immune Modulation.

Song J, Zhao R, Yan C, et al.

Frontiers in immunology 2022; (13()):746068 doi:10.3389/fimmu.2022.746068.

Ocular myasthenia gravis: a review and practical guide for clinicians.

Shuey NH

Clinical & experimental optometry 2022; (105(2)):205-213 doi:10.1080/08164622.2022.2029683.

Do early prednisolone and other immunosuppressant therapies prevent generalization in ocular myasthenia gravis in Western populations: a systematic review and meta-analysis.

Li M, Ge F, Guo R, et al.

Therapeutic advances in neurological disorders 2019; (12()):1756286419876521 doi:10.1177/1756286419876521.

Myasthenia Gravis: A Rare Neurologic Complication of Immune Checkpoint Inhibitor Therapy.

Shames Y, Errante M, Keteku NP

Journal of the advanced practitioner in oncology 2022; (13(2)):151-157 doi:10.6004/jadpro.2022.13.2.6.

An Interesting Case of Fatal Myasthenic Crisis Probably Induced by the COVID-19 Vaccine.

Sonigra KJ, Sarna K, Vaghela VP, Guthua S

Cureus 2022; (14(3)):e23251 doi:10.7759/cureus.23251.

A Case of COVID-19 With Myasthenic Crisis.

Xia C, Butler E, Edwards R, Amarasinghe N

Cureus 2022; (14(5)):e24936 doi:10.7759/cureus.24936.

Clinical value of cell-based assays in the characterisation of seronegative myasthenia gravis.

Damato V, Spagni G, Monte G, et al.

Journal of neurology, neurosurgery, and psychiatry 2022; (93(9)):995-1000 doi:10.1136/jnnp-2022-329284.

Seronegative Ocular Myasthenia Gravis in an Older Woman With Transient Dizziness and Diplopia.

Yoshioka N, Naito Y, Sano K, et al.

Cureus 2022; (14(8)):e27826 doi:10.7759/cureus.27826.

Comparison of Fixed and Live Cell-Based Assay for the Detection of AChR and MuSK Antibodies in Myasthenia Gravis.

Spagni G, Gastaldi M, Businaro P, et al.

Neurology(R) neuroimmunology & neuroinflammation 2023; (10(1)) doi:10.1212/NXI.0000000000200038.

Sorting nexin 17 increases low-density lipoprotein receptor-related protein 4 membrane expression: A novel mechanism of acetylcholine receptor aggregation in myasthenia gravis.

He X, Zhou S, Ji Y, et al.

Frontiers in immunology 2022; (13()):916098 doi:10.3389/fimmu.2022.916098.

Rituximab in Myasthenia Gravis- Experience from a Low- and Middle-Income Country (LMIC) Setting.

Shivaram S, Nagappa M, Varghese N, et al.

Neurology India 2022; (70(5)):1931-1941 doi:10.4103/0028-3886.359277.

Dynamic nomogram for predicting generalized conversion in adult-onset ocular myasthenia gravis.

Bi Z, Cao Y, Gui M, et al.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2023; (44(4)):1383-1391 doi:10.1007/s10072-022-06519-5.

Myasthenia Gravis and Lambert-Eaton Myasthenic Syndrome: New Developments in Diagnosis and Treatment.

Pascuzzi RM, Bodkin CL

Neuropsychiatric disease and treatment 2022; (18()):3001-3022 doi:10.2147/NDT.S296714.

Analysis of influencing factors of postoperative myasthenic crisis in 564 patients with myasthenia gravis in a single center.

Jiao P, Wu F, Liu Y, et al.

Thoracic cancer 2023; (14(5)):517-523 doi:10.1111/1759-7714.14774.

Patient-reported burden of myasthenia gravis: baseline results of the international prospective, observational, longitudinal real-world digital study MyRealWorld-MG.

Dewilde S, Philips G, Paci S, et al.

BMJ open 2023; (13(1)):e066445 doi:10.1136/bmjopen-2022-066445.

Autoantibody detection by a live cell-based assay in conventionally antibody-tested triple seronegative Myasthenia gravis.

Hoffmann S, Waters P, Jacobson L, et al.

Neuromuscular disorders : NMD 2023; (33(2)):139-144 doi:10.1016/j.nmd.2023.01.002.

Myasthenia gravis with achalasia secondary to thymoma: a case report and literature review.

Haridy NA, Khedr EM, Hasan AM, et al.

The Egyptian journal of neurology, psychiatry and neurosurgery 2023; (59(1)):34 doi:10.1186/s41983-023-00636-4.

Atypical Seropositive Striated Muscle Antibody Myasthenia Gravis Presentation With Metastatic B1 Thymoma: A Rare Case.

Randhawa JS, Kim LS, Aguilar C, et al.

Cureus 2023; (15(2)):e35221 doi:10.7759/cureus.35221.

The impact of thymectomy in subgroups of Myasthenia gravis patients: a single center longitudinal observation.

Menghesha H, Schroeter M, Nelke C, et al.

Neurological research and practice 2023; (5(1)):24 doi:10.1186/s42466-023-00252-w.

Challenges in Diagnosing and Treating Myasthenia Gravis in Infants and Children with Presentation of Cases.

Bricoune O, Hamner B, Gieron-Korthals M

Advances in pediatrics 2023; (70(1)):81-90 doi:10.1016/j.yapd.2023.03.007.

Occurrence and severity of myasthenic crisis in an unselected Turkish cohort of patients with myasthenia gravis.

Ozyurt Kose S, Nazli E, Tutkavul K, Gilhus NE

Frontiers in neurology 2023; (14()):1201451 doi:10.3389/fneur.2023.1201451.

Diplopia in a patient presenting with "blurred vision": a case report.

Harrison A, Mudhar O, Yoo J, Rampal M

Journal of medical case reports 2023; (17(1)):402 doi:10.1186/s13256-023-04089-4.

Effect of efgartigimod on muscle group subdomains in participants with generalized myasthenia gravis: post hoc analyses of the phase 3 pivotal ADAPT study.

Bril V, Howard JF, Karam C, et al.

European journal of neurology 2024; (31(1)):e16098 doi:10.1111/ene.16098.

Ravulizumab in Myasthenia Gravis: A Review of the Current Evidence.

Vu T, Wiendl H, Katsuno M, et al.

Neuropsychiatric disease and treatment 2023; (19()):2639-2655 doi:10.2147/NDT.S374694.

Plasma Exchange versus Intravenous Immunoglobulin in Worsening Myasthenia Gravis: A Systematic Review and Meta-Analysis with Special Attention to Faster Relapse Control.

Pavlekovics M, Engh MA, Lugosi K, et al.

Biomedicines 2023; (11(12)) doi:10.3390/biomedicines11123180.

Electrophysiological evaluation of the neuromuscular junction: a brief review.

Kouyoumdjian JA, Estephan EP

Arquivos de neuro-psiquiatria 2023; (81(12)):1040-1052 doi:10.1055/s-0043-1777749.

The Incidence of Myasthenia Gravis in the Province of Ferrara, Italy, in the Period of 2008-2022: An Update on a 40-Year Observation and the Influence of the COVID-19 Pandemic.

Antonioni A, Raho EM, Carlucci D, et al.

Journal of clinical medicine 2023; (13(1)) doi:10.3390/jcm13010236.

How should newer therapeutic agents be incorporated into the treatment of patients with myasthenia gravis?

Gwathmey KG, Ding H, Hehir M, Silvestri N

Muscle & nerve 2024; (69(4)):389-396 doi:10.1002/mus.28038.

Terminal Complement Inhibitor Ravulizumab in Generalized Myasthenia Gravis.

Vu T, Meisel A, Mantegazza R, et al.

NEJM evidence 2022; (1(5)):EVIDoa2100066 doi:10.1056/EVIDoa2100066.

Acute onset of Lambert Eaton myasthenic syndrome in prostate adenocarcinoma: a case report.

Drăghici NC, Olariu E, Lupescu TD, Mureşanu FD

Medicine and pharmacy reports 2024; (97(1)):95-98 doi:10.15386/mpr-2541.

Defective autophagy and autophagy activators in myasthenia gravis: a rare entity and unusual scenario.

Al-Kuraishy HM, Sulaiman GM, Jabir MS, et al.

Autophagy 2024; (20(7)):1473-1482 doi:10.1080/15548627.2024.2315893.

Stimulated Single Fiber Electromyography (SFEMG) for Assessing Neuromuscular Junction Transmission in Rodent Models.

Ketabforoush A, Wang M, Arnold WD

Journal of visualized experiments : JoVE 2024; doi:10.3791/66452.

Study on the clinical and electrophysiological characteristics of nerve function in myasthenia gravis patients in Vietnam.

Anh Pham TK, Van Pham P, Dinh Le T, et al.

SAGE open medicine 2024; (12()):20503121241229591 doi:10.1177/20503121241229591.

Lady With the Blue Hair: An Atypical Cause of Myasthenic Crisis.

Gomez Rosado JO, Perez T, Fusco KN, et al.

Cureus 2024; (16(5)):e60186 doi:10.7759/cureus.60186.

Analysis of events from sudden isolated dysarthria to diagnosis of myasthenic crisis: myasthenia gravis mimicking acute lacunar stroke-a case report.

Miletic SP, Ahmed SRB

Journal of medical case reports 2024; (18(1)):319 doi:10.1186/s13256-024-04617-w.

Psychometric properties of MG-ADL items and MG-ADL score: An assessment of distributional characteristics, validity and factor structure in two large datasets.

Janssen MF, Dewilde S, Wolfe GI, et al.

Journal of the neurological sciences 2024; (463()):123135 doi:10.1016/j.jns.2024.123135.

Clinical and laboratory remission with rituximab in anti-MuSK-positive myasthenia gravis.

Inan B, Orhan IG, Bekircan-Kurt CE, et al.

Irish journal of medical science 2024; (193(6)):2989-2994 doi:10.1007/s11845-024-03763-w.

Application of Electrophysiological Techniques in Assessing of Neuromuscular Junction-Related Disorders.

Yang XG, Guo HY, Peng Z, et al.

World neurosurgery 2024; (191()):165-171 doi:10.1016/j.wneu.2024.08.076.

Myasthenia gravis.

Pasnoor M, Wolfe GI, Barohn RJ

Handbook of clinical neurology 2024; (203()):185-203 doi:10.1016/B978-0-323-90820-7.00006-9.

Efgartigimod combined with steroids as a fast-acting therapy for myasthenic crisis: a case report.

Ohara H, Kikutsuji N, Iguchi N, Kinoshita M

BMC neurology 2024; (24(1)):292 doi:10.1186/s12883-024-03804-y.

Thymoma-Related Chest Pain and Dyspnea in a Middle-Aged Caucasian Female With Myasthenia Gravis and Good's Syndrome: A Case Report.

Ansari AZ, Koi T, Lief S, et al.

Cureus 2024; (16(8)):e68027 doi:10.7759/cureus.68027.

Time to response with ravulizumab, a long-acting terminal complement inhibitor, in adults with anti-acetylcholine receptor antibody-positive generalized myasthenia gravis.

Habib AA, Benatar M, Vu T, et al.

European journal of neurology 2024; (31(12)):e16490 doi:10.1111/ene.16490.

Telitacicept in combination with B-cell depletion therapy in MuSK antibody-positive myasthenia gravis: a case report and literature review.

Wang J, Zheng H, Wei J, et al.

Frontiers in immunology 2024; (15()):1456822 doi:10.3389/fimmu.2024.1456822.

Myasthenia gravis: The evolving therapeutic landscape.

Wolfe GI, Hanson JE, Silvestri NJ

eNeurologicalSci 2024; (37()):100541 doi:10.1016/j.ensci.2024.100541.

A clinical perspective on muscle specific kinase antibody positive myasthenia gravis.

Keritam O, Vincent A, Zimprich F, Cetin H

Frontiers in immunology 2024; (15()):1502480 doi:10.3389/fimmu.2024.1502480.

Infectious Thoracoabdominal Aortic Aneurysm Repair in a Patient with Myasthenia Gravis: A Case Report.

Chiba K, Kinebuchi S, Komagamine M, et al.

Annals of vascular diseases 2024; (17(4)):429-432 doi:10.3400/avd.cr.24-00099.

Pathogenesis and detection methods of anti-acetylcholine receptor antibodies in myasthenia gravis.

Suzuki S

Immunological medicine 2025; (48(2)):117-123 doi:10.1080/25785826.2025.2472449.

Efficacy and safety of rituximab in anti-MuSK myasthenia Gravis: a systematic review and meta-analysis.

Chayanopparat S, Banyatcharoen P, Jitprapaikulsan J, et al.

Scientific reports 2025; (15(1)):7219 doi:10.1038/s41598-025-90937-w.

Atypical presentation of Lambert-Eaton myasthenic syndrome associated with oesophageal squamous cell carcinoma.

Bubuioc AM, Gagiu A, Cojocaru L, Lisnic V

BMJ case reports 2025; (18(3)) doi:10.1136/bcr-2024-264472.

Case Report: A myasthenia gravis patient complicated with renal failure was effectively treated with efgartigimod.

Ke J, Zhao Q, Wang N, et al.

Frontiers in immunology 2025; (16()):1526975 doi:10.3389/fimmu.2025.1526975.

Late-Onset Autoimmune Myasthenia Gravis: A Diagnosis Not to Be Overlooked in the Elderly.

Zulfiqar AA

Cureus 2025; (17(4)):e82707 doi:10.7759/cureus.82707.

MuSK cysteine-rich domain antibodies are pathogenic in a mouse model of autoimmune myasthenia gravis.

Halliez M, Cottin S, You A, et al.

The Journal of clinical investigation 2025; (135(15)).

Mycobacterium abscessus Pulmonary Disease in a Myasthenia Gravis Patient: A Case Report.

Lu D, Tong SYC, Cruse B, et al.

Respirology case reports 2025; (13(7)):e70166 doi:10.1002/rcr2.70166.

Structure and function of the neuromuscular junction in health and myasthenia gravis.

Plomp JJ, Webster RG

International review of neurobiology 2025; (182()):1-19 doi:10.1016/bs.irn.2025.04.036.

Special populations in myasthenia gravis: Early, late, and very late-onset MG.

Hoffmann S

International review of neurobiology 2025; (182()):197-204 doi:10.1016/bs.irn.2025.04.032.

Autoantibodies in myasthenia gravis.

Fichtner ML, Horstkorte L, Sánchez Navarro BG, et al.

International review of neurobiology 2025; (182()):89-119 doi:10.1016/bs.irn.2025.04.024.

Outcomes of myasthenia gravis patients admitted to the Intensive Care Unit: Experience from a tertiary care center in Saudi Arabia.

Attar A, Alshaikh H, Alharbi G, et al.

PloS one 2025; (20(7)):e0328648 doi:10.1371/journal.pone.0328648.

The Diagnostic Yield of Antiacetylcholine Receptor Antibodies Versus Antimuscle Kinase Antibodies in Ocular Myasthenia Gravis: A Meta-Analysis.

Tran E, Nair G, Bursztyn LLCD, et al.

Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society 2025; doi:10.1097/WNO.0000000000002382.

Factors associated with early response to efgartigimod in patients with generalized myasthenia gravis: a multicenter retrospective observational study.

Zhu W, Chen Y, Tian C, et al.

Journal of neurology 2025; (272(9)):622 doi:10.1007/s00415-025-13367-8.

Botulism, Lambert-Eaton Myasthenic Syndrome, and Congenital Myasthenic Syndromes.

Ramdas S

Continuum (Minneapolis, Minn.) 2025; (31(5)):1303-1328 doi:10.1212/cont.0000000000001613.

The clinical evaluation of myasthenia gravis.

Europa TA, Wong SH, Heckmann JM

International review of neurobiology 2025; (183()):31-44 doi:10.1016/bs.irn.2025.04.017.

Severe Seronegative Myasthenia Gravis Revealed by Rapidly Progressive Dysphagia.

Ramos Huamancondor C, Bronchain M, Petit J

Cureus 2025; (17(10)):e93839 doi:10.7759/cureus.93839.

Effects of Thymectomy in Late-Onset Myasthenia Gravis: A Multi-Center Longitudinal Retrospective Study.

Chen J, Su C, Feng L, et al.

Annals of neurology 2026; (99(3)):629-638 doi:10.1002/ana.78093.

Clinical and economic outcomes of myasthenia gravis and myasthenic crisis when treated with PLEX and IVIG.

Maroney M, Diehl T, Blaney E, et al.

Frontiers in neurology 2025; (16()):1713388 doi:10.3389/fneur.2025.1713388.

Myasthenia Gravis - An Updated Review.

Harish Bindignavile S

International ophthalmology clinics 2026; (66(1)):55-61 doi:10.1097/IIO.0000000000000600.

Efgartigimod for Generalized Myasthenia Gravis and Beyond: A Narrative Review of Its Pharmacological Profile, Clinical Utility, and Expanding Applications.

Mansour GK, Alangari L, Khosyfan L, et al.

Biomedicines 2025; (13(12)) doi:10.3390/biomedicines13122975.

Thymic Hyperplasias in Practice: Clinical Context, Histological Clues, and Management Implications.

Porubsky S

Cancers 2025; (18(1)) doi:10.3390/cancers18010084.

Clinical Features and Outcomes of Ocular Myasthenia Gravis in a Tertiary Philippine Hospital.

Labiano AT, Cruz FMO, Mesina BVQ

Acta medica Philippina 2025; (59(20)):47-53 doi:10.47895/amp.vi0.11557.

Unilateral Ptosis and Bulbar Symptoms as the Initial Presentation of Late-Onset Acetylcholine Receptor Antibody-Positive Myasthenia Gravis Mimicking Acute Ischemic Stroke in an 82-Year-Old Man.

Mangrio SM, Faisal S, Malik Z, et al.

Cureus 2025; (17(12)):e99832 doi:10.7759/cureus.99832.

Electrodiagnostic Approach to Defects of Neuromuscular Transmission.

Morena JM

Muscle & nerve 2026; doi:10.1002/mus.70146.

Rapid efficacy of efgartigimod for generalized myasthenia gravis patients in acute exacerbations/worsening: multicenter real-world retrospective study.

Lin J, Chang T, Xiao L, et al.

Journal of neurology 2026; (273(2)):146 doi:10.1007/s00415-026-13695-3.

The Duke MG Patient Registry III. Comparative Effectiveness of Azathioprine and Mycophenolate Mofetil in Generalized Myasthenia Gravis, a Retrospective Single Center Review.

Sanders DB, Lutz MW, Raja SM, et al.

Muscle & nerve 2026; doi:10.1002/mus.70177.

A comprehensive electrooculography measurement system and protocols for screening myasthenia gravis.

Le TL, Boulos MI, Yang D, et al.

MethodsX 2026; (16()):103810 doi:10.1016/j.mex.2026.103810.